Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECT in Schizophrenia and Bipolar Disorder
NCT03651674Unknown
- Sponsor
- Xidian University
- Start
- Sep 2018
- Primary completion
- Dec 2019
01
Overview
Open-label trial in schizophrenia and bipolar disorder (BD) (2 arms), sponsored by Xidian University. Primary endpoints: Positive And Negative Syndrome Scale at 3 months, Bech-Rafaelsen Mania Rating Scale at 3 months and 2 more. Status: unknown.
02
Conditions
schizophreniabipolar disorder (BD)
Beyond the preview
Go deeper on NCT03651674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03651674.